European heart device will reach US patients first. EU is failing to fund innovation, its CEO says

EU PERSPECTIVES - A European company is developing a device that could help doctors better manage heart failure. Yet, US patients will get it first. Its CEO says in an interview that the EU's reimbursement system is to blame. Read more

Acorai CEO Filip Peters says the EU's reimbursement system is making it harder for European medtech companies to bring breakthrough technologies to patients. / Photo: Filip Peters' archive